• Korean Journal of Environmental Biology
• /
• v.27 no.1
• /
• pp.100-109
• /
• 2009

Korean Plecopteran research was started in 1921, and it has advanced greatly during last 20 years. Among families the family Nemouridae and Chloroperlidae are composed of plentiful species. Since North Korean Plecopteran research was begun in 1938, it made good progress by foreigners not North Korean in the 1970's. Subsequently a few species has been added up recently, and among families the family Perlidae and Nemouridae contain most abundant species. Totally Korean Plecoptera consists of 43 species in 25 genera in 10 families, and North Korean 37 species in 26 genera in 10 families. Among them 13 species are common in both. And Korean names of Plecopteran species were mixed in Hangeul-type and Chinese-type, on the other hand in North Korean names there were some cases of Hangeul-type, but most of species have no Korean names. In Korea, particularly Ministry of Environment designated and controlled domestic biological resources as Korean Species that Require Approval when shipping abroad and Korean endemic species, which include 9 species and 11 species in Plecoptera respectively. Finally two genera and four species gained new Korean names as follows: genus Megaleuctra (Keun-Kkoma-Gang-Do-Rae-Sok), genus Haploperla (Han-Nok-Saek-Gang-Do-Rae-Sok), Nemoura brevicercia (Min-Gang-Do-Rae), Nemoura espera (Kkot-Min-Gang-Do-Rae), Amphinemura baei (Je-Ju-A-Ga-Mi-Min-GangDo-Rae) and Amphinemura rai (A-Ga-Mi-Min-Gang-Do-Rae).

• Journal of Korean Medical classics
• /
• v.36 no.4
• /
• pp.109-130
• /
• 2023

Objectives : The Dong-hwa Yakbang Cheobangcheol, a formulary on proprietary medicines created by Dong-hwa Pharmacy in the early 20th century was analyzed with a focus on characteristics of the formulas that were made and sold at the time. Methods : First, external features such as bibliography, table of contents, and descriptive style were examined. In content, licensure of listed formulas, ingredients, dosage form, manufacturing process, effects, properties were medically and pharmacologically analyzed. In this process, the Japanese Pharmacopeial Convention, legislation related to medicinal pharmacology during Japanese Colonial Period, and the Donguibogam were referenced. Results : In terms of form, the Dong-hwa Yakbang Cheobangcheol faithfully follows medicinal related legislation established in the Japanese Colonial Period. However, in terms of content, we could see that most of the formulas were based on the Korean Medical tradition, while Western pharmaceutical technology and chemicals were selectively integrated when necessary. Conclusions : The Dong-hwa Yakbang Cheobangcheol comprehensively displays the situation and goal of Dong-hwa Pharmacy, one of the most representative pharmaceutical companies in proprietary medicine of the early 20th century, in which it was under pressure to adapt to power for survival, while it strived to help improve the health of the people of the time by adopting strengths of both Eastern and Western medicinals.